| Pulmonary Embolism |
1 |
1 |
| Thromboembolism |
0 |
1 |
| Embolism |
0 |
0.51 |
| Hospital |
0 |
0.41 |
| Cerebrovascular Accident |
0 |
0.38 |
| Blood |
0 |
0.3 |
| Thrombolytic Therapy |
0 |
0.3 |
| Blood Vessel |
0 |
0.29 |
| Intracranial Hemorrhage |
0 |
0.24 |
| Cardiac Arrest |
0 |
0.2 |
| Europe |
0 |
0.2 |
| Hemodynamics |
0 |
0.2 |
| Hemorrhage |
0 |
0.2 |
| Surgery |
0 |
0.2 |
| Patient Safety |
0 |
0.19 |
| Extracorporeal Membrane Oxygenation (ECMO) |
0 |
0.17 |
| Tissue Plasminogen Activator |
0 |
0.14 |
| Traumatic Brain Injury |
0 |
0.13 |
| Adverse Effects |
0 |
0.1 |
| Anemia |
0 |
0.1 |
| Anticoagulation Therapy |
0 |
0.1 |
| Artery |
0 |
0.1 |
| Cancer |
0 |
0.1 |
| Cannulation |
0 |
0.1 |
| Clinical Research |
0 |
0.1 |
| France |
0 |
0.1 |
| Grant |
0 |
0.1 |
| Intensive Care Unit |
0 |
0.1 |
| Intravenous |
0 |
0.1 |
| Shock |
0 |
0.1 |
| Thrombectomy |
0 |
0.1 |
| Tissue |
0 |
0.1 |
| Complementary and Alternative Medicine |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.06 |